Vivaldi Coelho Rogerio - Net Worth and Insider Trading
Vivaldi Coelho Rogerio Net Worth
The estimated net worth of Vivaldi Coelho Rogerio is at least $2 Million dollars as of 2024-12-27. Vivaldi Coelho Rogerio is the Chief Commercial Officer of Spark Therapeutics Inc and owns about 18,716 shares of Spark Therapeutics Inc (ONCE) stock worth over $2 Million. Vivaldi Coelho Rogerio is also the Director of Crinetics Pharmaceuticals Inc and owns about 5,000 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $269,600. Details can be seen in Vivaldi Coelho Rogerio's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivaldi Coelho Rogerio has not made any transactions after 2023-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vivaldi Coelho Rogerio
Vivaldi Coelho Rogerio Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivaldi Coelho Rogerio owns 5 companies in total, including Bioverativ Inc (BIVV) , Spark Therapeutics Inc (ONCE) , and Minerva Neurosciences Inc (NERV) among others .
Click here to see the complete history of Vivaldi Coelho Rogerio’s form 4 insider trades.
Insider Ownership Summary of Vivaldi Coelho Rogerio
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIVV | Bioverativ Inc | 2018-03-08 | EVP & Chief Global Therapeutics |
| ONCE | Spark Therapeutics Inc | 2016-07-15 | Chief Commercial Officer |
| NERV | Minerva Neurosciences Inc | 2014-06-30 | director & President and CEO |
 | | 2023-06-08 | director |
| | 2020-12-03 | director & President and CEO |
Vivaldi Coelho Rogerio Latest Holdings Summary
Vivaldi Coelho Rogerio currently owns a total of 2 stocks. Among these stocks, Vivaldi Coelho Rogerio owns 18,716 shares of Spark Therapeutics Inc (ONCE) as of July 15, 2016, with a value of $2 Million and a weighting of 88.74%. Vivaldi Coelho Rogerio also owns 5,000 shares of Crinetics Pharmaceuticals Inc (CRNX) as of June 8, 2023, with a value of $269,600 and a weighting of 11.26%.
Latest Holdings of Vivaldi Coelho Rogerio
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCE | Spark Therapeutics Inc | 2016-07-15 | 18,716 | 113.57 | 2,125,576 |
| CRNX | Crinetics Pharmaceuticals Inc | 2023-06-08 | 5,000 | 53.92 | 269,600 |
Holding Weightings of Vivaldi Coelho Rogerio
Vivaldi Coelho Rogerio Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivaldi Coelho Rogerio has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 7,000 shares on July 15, 2016, which brought Vivaldi Coelho Rogerio around $371,210.
According to the SEC Form 4 filings, Vivaldi Coelho Rogerio has made a total of 1 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the acquisition of 5,000 shares on June 8, 2023, which cost Vivaldi Coelho Rogerio around $110,300.
Insider Trading History of Vivaldi Coelho Rogerio
- 1
Vivaldi Coelho Rogerio Trading Performance
GuruFocus tracks the stock performance after each of Vivaldi Coelho Rogerio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivaldi Coelho Rogerio is -27.28%. GuruFocus also compares Vivaldi Coelho Rogerio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivaldi Coelho Rogerio within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vivaldi Coelho Rogerio's insider trading performs compared to the benchmark.
Performance of Vivaldi Coelho Rogerio
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.94 | | | | | |
| Relative Return to S&P 500(%) | -17.39 | | | | | |
Vivaldi Coelho Rogerio Ownership Network
Vivaldi Coelho Rogerio Owned Company Details
What does Bioverativ Inc do?
Who are the key executives at Bioverativ Inc?
Vivaldi Coelho Rogerio is the EVP & Chief Global Therapeutics of Bioverativ Inc. Other key executives at Bioverativ Inc include director & Chief Executive Officer John Cox , EVP & CFO and Treasurer John Greene , and Chief Accounting Officer Diantha Duvall .
Bioverativ Inc (BIVV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bioverativ Inc (BIVV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bioverativ Inc (BIVV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bioverativ Inc (BIVV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bioverativ Inc Insider Transactions
Vivaldi Coelho Rogerio Mailing Address
Above is the net worth, insider trading, and ownership report for Vivaldi Coelho Rogerio. You might contact Vivaldi Coelho Rogerio via mailing address: 225 Second Avenue, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
